FDA NDC Directory · JSON-LD · Markdown

Increlex

NDC 15054-1040 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namemecasermin
Labeler / ManufacturerIpsen Biopharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA021839
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsMECASERMIN (40 mg/4mL)
Marketing started20060103
Marketing ended20271231
Package count1

External sources

Source: openFDA. Public-domain (CC0).